Evanthia Galanis, MD
Enriched profileGroup Chair, Alliance for Clinical Trials in Oncology; Sandra J. Schulze Professor of Novel Therapeutics and Professor of Oncology, Mayo Clinic · Mayo Clinic
Evanthia Galanis is Group Chair, Alliance for Clinical Trials in Oncology; Sandra J. Schulze Professor of Novel Therapeutics and Professor of Oncology, Mayo Clinic at Mayo Clinic. OpenAlex indexes 431 publications with 27,798 citations (h-index 80); ClinicalTrials.gov lists 25 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Evanthia Galanis, MD, is Group Chair, Alliance for Clinical Trials in Oncology at Mayo Clinic, Rochester, MN. The public record shows 431 publications with 27,798 citations (h-index 80), centered on Glioma Diagnosis and Treatment, Virus-based gene therapy research, Brain Metastases and Treatment. It also documents an investigator role on 25 registered clinical trials, industry payments reported by 2 companies, 13 NIH-funded awards (2000–2025).
- Most recent indexed publication: 2026 · Nature medicine
- Top research focus: Glioma Diagnosis and Treatment
- 25 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 234.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:
- Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Sponsor: Alliance Foundation Trials, LLC.
- Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
Sponsor: Alliance Foundation Trials, LLC.
- Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide
Sponsor: Alliance Foundation Trials, LLC.
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year20247 payments$18,259openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
69.5%PD-1 inhibitor33.9%Pembrolizumab100%Part B, office-administered≥34 patientsMicrotubule Inhibitor19.3%Paclitaxel100%Part B, office-administered≥24 patientsMetabolism & gastrointestinal
26.5%Other antiemetics22.1%Fosaprepitant100%Part B, office-administered≥31 patientsSerotonin-3 Receptor Antagonist4.3%Palonosetron hcl57%Ondansetron hydrochloride43%Part B, office-administered≥53 patientsSensory organs
3.7%Corticosteroid3.7%Dexamethasone sodium phosphate100%Part B, office-administered≥70 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
13 NIH research awards on record, funded 2000–2025 per NIH RePORTER. The latest:
- Alliance for Clinical Trials in Oncology Administrative Core
Alliance Nctn Foundation
FY2026$9,575,686U10CA180821 - Alliance for Clinical Trials in Oncology Operations Center
Alliance Nctn Foundation
FY2026$6,719,624U10CA180821 - Alliance for Clinical Trials in Oncology Member Site Core
Alliance Nctn Foundation
FY2026$3,523,972U10CA180821
Congress activity
Updated 27 Aug 2026
51 congress contributions (2004–2025) across AACR, ASCO, ASTRO per OpenAlex. The most recent:
- Retifanlimab with bevacizumab and hypofractionated radiotherapy to treat recurrent glioblastoma.
ASCO Annual Meeting
ASCO2025Co-author - The impact of IDH mutation and 1p/19q codeletion on immune-checkpoint inhibitor efficacy in recurrent gliomas.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.
Nature medicine
Clinical Trial2026 - Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, IDH-wildtype.
Neuro-oncology advances
Article2026 - Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30.
Neuro-oncology
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/evanthia-galanis-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Evanthia-Galanis-38937787
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/MayoClinic/photos/oncologist-evanthia-galanis-md-is-passionate-about-making-a-difference-and-she-i/10156998954597517
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/MayoClinic/posts/as-a-medical-oncologist-evanthia-galanis-md-has-a-simple-philosophy-patients-nee/10156646401227517
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
data.the-asci.org/controllers/asci/DirectoryController.php
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →data.the-asci.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mesotheliomadr.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allianceforclinicaltrialsinoncology.org ↗
- Board Certified
Medical Oncology (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - M.D.
National and Kapodistrian University of Athens School of Medicine (Athens University School of Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗ - Residency
Internal Medicine, and Fellowship, Hematology/Oncology, Mayo Graduate School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗ - Board certified
Internal Medicine and Medical Oncology (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- President-elect (subsequently active leadership)
Society for Neuro-Oncology; author/contributor to SNO's 30th-anniversary retrospective
2026provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic.oup.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancerletter.com ↗
- Group Chair
Alliance for Clinical Trials in Oncology (elected Chair-Elect May 2023; term as Chair began November 2023, six-year term); previously Chair, Alliance Neuro-Oncology Committee, member since 2011
2011verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allianceforclinicaltrialsinoncology.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →wikidata.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayo.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →alumniassociation.mayo.edu ↗
Media & interviews
press, podcasts and appearances- Feature profile
"A Physician's Love for Philosophy Grows Into a Passion for Practicing Medical Oncology to Help Patients," Mayo Clinic Magazine
2019provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayomagazine.mayoclinic.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newsnetwork.mayoclinic.org ↗
- "Science Saturday: Bitten by the virotherapy bug"
Mayo Clinic News Network feature on her virotherapy research and personal motivation (father's melanoma)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newsnetwork.mayoclinic.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic